PubMed

Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17).

Scheen AJ, Tan MH, Betteridge DJ, Birkeland K, Schmitz O, Charbonnel B; PROactive investigators.

Diabet Med. 2009 Oct;26(10):1033-9.PMID: 19900236 [PubMed - in process]Related articles

Long-term lipid effects of pioglitazone by baseline anti-hyperglycemia medication therapy and statin use from the PROactive experience (PROactive 14).

Spanheimer R, Betteridge DJ, Tan MH, Ferrannini E, Charbonnel B; PROactive Investigators.

Am J Cardiol. 2009 Jul 15;104(2):234-9. Epub 2009 Jun 3.PMID: 19576353 [PubMed - indexed for MEDLINE]Related articles

PPAR-alpha and PPAR-gamma agonists for type 2 diabetes.

Charbonnel B.

Lancet. 2009 Jul 11;374(9684):96-8. Epub 2009 Jun 8. Review. No abstract available. PMID: 19515412 [PubMed - indexed for MEDLINE]Related articles

A corticotroph pituitary adenoma as the initial presentation of familial glucocorticoid deficiency.

Benoit I, Drui D, Chaillous L, Dupas B, Mosnier JF, Charbonnel B, Cariou B.

Eur J Endocrinol. 2009 Jul;161(1):195-9. Epub 2009 May 7.PMID: 19423561 [PubMed - indexed for MEDLINE]Related articles

Abdominal obesity is associated with ineffective control of cardiovascular risk factors in primary care in France.

Dallongeville J, Bringer J, Bruckert E, Charbonnel B, Dievart F, Komajda M, Pouchain D, Amouyel P.

Diabetes Metab. 2008 Dec;34(6 Pt 1):606-11. Epub 2008 Nov 18.PMID: 19019717 [PubMed - indexed for MEDLINE]Related articles

Fulminant type 1 diabetes in Caucasians: A report of three cases.

Moreau C, Drui D, Arnault-Ouary G, Charbonnel B, Chaillous L, Cariou B.

Diabetes Metab. 2008 Nov;34(5):529-32. Epub 2008 Oct 1.PMID: 18829363 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach.

Xu L, Man CD, Charbonnel B, Meninger G, Davies MJ, Williams-Herman D, Cobelli C, Stein PP.

Diabetes Obes Metab. 2008 Dec;10(12):1212-20. Epub 2008 May 12.PMID: 18476982 [PubMed - indexed for MEDLINE]Related articles

Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.

Mirallié E, Guillan T, Bridji B, Resche I, Rousseau C, Ansquer C, Bodet-Milin C, Curtet C, Carnaille B, Murat A, Charbonnel B, Kraeber-Bodéré F.

Surgery. 2007 Dec;142(6):952-8; discussion 952-8.PMID: 18063081 [PubMed - indexed for MEDLINE]Related articles

Glitazones in the treatment of diabetes mellitus: clinical outcomes in large scale clinical trials.

Charbonnel B.

Fundam Clin Pharmacol. 2007 Nov;21 Suppl 2:19-20. Review.PMID: 18001315 [PubMed - indexed for MEDLINE]Related articles

PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study.

Erdmann E, Dormandy J, Wilcox R, Massi-Benedetti M, Charbonnel B.

Vasc Health Risk Manag. 2007;3(4):355-70. Review.PMID: 17969365 [PubMed - indexed for MEDLINE]Related articlesFree article

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).

Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA; PROactive investigators.

Diabetes Care. 2007 Nov;30(11):2773-8. Epub 2007 Jul 31.PMID: 17666462 [PubMed - indexed for MEDLINE]Related articlesFree article

Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.

Charbonnel B.

Int J Clin Pract Suppl. 2007 Jun;(153):1-2. Review. No abstract available. Erratum in: Int J Clin Pract Suppl. 2007 Oct;61(10):1776. PMID: 17594387 [PubMed - indexed for MEDLINE]Related articles

Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.

Blancou P, Mallone R, Martinuzzi E, Sévère S, Pogu S, Novelli G, Bruno G, Charbonnel B, Dolz M, Chaillous L, van Endert P, Bach JM.

J Immunol. 2007 Jun 1;178(11):7458-66.PMID: 17513797 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.

Erdmann E, Dormandy JA, Charbonnel B, Massi-Benedetti M, Moules IK, Skene AM; PROactive Investigators.

J Am Coll Cardiol. 2007 May 1;49(17):1772-80. Epub 2007 Apr 16.PMID: 17466227 [PubMed - indexed for MEDLINE]Related articles

Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up).

Caillard C, Sebag F, Mathonnet M, Gibelin H, Brunaud L, Loudot C, Kraimps JL, Hamy A, Bresler L, Charbonnel B, Leborgne J, Henry JF, Nguyen JM, Mirallié E.

Surgery. 2007 Feb;141(2):153-9; discussion 159-60.PMID: 17263969 [PubMed - indexed for MEDLINE]Related articles

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyörälä K, Raz I, Schernthaner G, Volpe M, Wood D; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD).

Eur Heart J. 2007 Jan;28(1):88-136. No abstract available. PMID: 17220161 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.

Charbonnel B, Karasik A, Liu J, Wu M, Meininger G; Sitagliptin Study 020 Group.

Diabetes Care. 2006 Dec;29(12):2638-43.PMID: 17130197 [PubMed - indexed for MEDLINE]Related articlesFree article

Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group.

Chatal JF, Campion L, Kraeber-Bodéré F, Bardet S, Vuillez JP, Charbonnel B, Rohmer V, Chang CH, Sharkey RM, Goldenberg DM, Barbet J; French Endocrine Tumor Group.

J Clin Oncol. 2006 Apr 10;24(11):1705-11. Epub 2006 Mar 20.PMID: 16549819 [PubMed - indexed for MEDLINE]Related articles

Are there specific care requirements for patients with schizophrenia and diabetes or with a risk of diabetes?

Thomas P, Raymondet P, Charbonnel B, Vaiva G.

Eur Psychiatry. 2005 Dec;20 Suppl 4:S358-63.PMID: 16459251 [PubMed - indexed for MEDLINE]Related articles

What a psychiatrist needs to know about diabetes.

Charbonnel B.

Eur Psychiatry. 2005 Dec;20 Suppl 4:S330-4.PMID: 16459246 [PubMed - indexed for MEDLINE]Related articles

[Metabolic syndrome and cardiovascular risk]

Charbonnel B.

Rev Prat. 2005 Oct 31;55(16):1765-71. Review. French. PMID: 16363426 [PubMed - indexed for MEDLINE]Related articles

Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases.

Kraeber-Bodéré F, Cariou B, Curtet C, Bridji B, Rousseau C, Dravet F, Charbonnel B, Carnaille B, Le Néel JC, Mirallié E.

Surgery. 2005 Dec;138(6):1176-82; discussion 1182.PMID: 16360406 [PubMed - indexed for MEDLINE]Related articles

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive investigators.

Lancet. 2005 Oct 8;366(9493):1279-89.PMID: 16214598 [PubMed - indexed for MEDLINE]Related articles

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.

Charbonnel B, Schernthaner G, Brunetti P, Matthews DR, Urquhart R, Tan MH, Hanefeld M.

Diabetologia. 2005 Jun;48(6):1093-104. Epub 2005 May 12.PMID: 15889234 [PubMed - indexed for MEDLINE]Related articles

Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.

Bourcigaux N, Arnault-Ouary G, Christol R, Périn L, Charbonnel B, Le Bouc Y.

Clin Ther. 2005 Feb;27(2):246-51.PMID: 15811488 [PubMed - indexed for MEDLINE]Related articles

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.

Charbonnel BH, Matthews DR, Schernthaner G, Hanefeld M, Brunetti P; QUARTET Study Group.

Diabet Med. 2005 Apr;22(4):399-405.PMID: 15787663 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone elicits long-term improvements in insulin sensitivity in patients with type 2 diabetes: comparisons with gliclazide-based regimens.

Charbonnel B, Roden M, Urquhart R, Mariz S, Johns D, Mihm M, Widel M, Tan M.

Diabetologia. 2005 Mar;48(3):553-60. Epub 2005 Mar 1.PMID: 15739120 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.

Schernthaner G, Matthews DR, Charbonnel B, Hanefeld M, Brunetti P; Quartet [corrected] Study Group.

J Clin Endocrinol Metab. 2004 Dec;89(12):6068-76. Erratum in: J Clin Endocrinol Metab. 2005 Feb;90(2):746. PMID: 15579760 [PubMed - indexed for MEDLINE]Related articlesFree article

High frequency of bone/bone marrow involvement in advanced medullary thyroid cancer.

Mirallié E, Vuillez JP, Bardet S, Frampas E, Dupas B, Ferrer L, Faivre-Chauvet A, Murat A, Charbonnel B, Barbet J, Goldenberg DM, Chatal JF, Kraeber-Bodéré F.

J Clin Endocrinol Metab. 2005 Feb;90(2):779-88. Epub 2004 Nov 30.PMID: 15572422 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.

Matthews DR, Charbonnel BH, Hanefeld M, Brunetti P, Schernthaner G.

Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):167-74.PMID: 15386821 [PubMed - indexed for MEDLINE]Related articles

Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.

Reznik Y, Lefebvre H, Rohmer V, Charbonnel B, Tabarin A, Rodien P, Lecomte P, Bardet S, Coffin C, Mahoudeau J; REHOS study group.

Clin Endocrinol (Oxf). 2004 Sep;61(3):311-9.PMID: 15355446 [PubMed - indexed for MEDLINE]Related articles

[Recommendations of SPC/ALFEDIAM on the care of diabetic patient as seen by the cardiologist]

Charbonnel B, Bouhanick B, Le Feuvre C; SFC/ALFEDIAM.

Diabetes Metab. 2004 Jun;30(3 Pt 2):S2-24. French. No abstract available. PMID: 15295297 [PubMed - indexed for MEDLINE]Related articlesFree article

The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients.

Charbonnel B, Dormandy J, Erdmann E, Massi-Benedetti M, Skene A; PROactive Study Group.

Diabetes Care. 2004 Jul;27(7):1647-53.PMID: 15220241 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

Clin Ther. 2004 Apr;26(4):502-10.PMID: 15189747 [PubMed - indexed for MEDLINE]Related articles

[SFC/ALFEDIAM (French Cardiology Society/French-speaking Association for the Study of Diabetes and Metabolic Diseases) guidelines on the management of the diabetic patient seen by a cardiologist. Recommendations, rationale, references]

Charbonnel B, Bouhanick B, Le Feuvre C; SFC/ALFEDIAM Groupe de travail.

Arch Mal Coeur Vaiss. 2004 Mar;97(3):229-49. French. No abstract available. PMID: 15106747 [PubMed - indexed for MEDLINE]Related articles

Management of French patients with type 2 diabetes mellitus in medical general practice: report of the Mediab observatory.

Monnier L, Grimaldi A, Charbonnel B, Iannascoli F, Lery T, Garofano A, Childs M; Mediab.

Diabetes Metab. 2004 Feb;30(1):35-42.PMID: 15029096 [PubMed - indexed for MEDLINE]Related articlesFree article

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.

Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B; ASIA Group.

Diabetes Metab. 2003 Dec;29(6):587-94.PMID: 14707887 [PubMed - indexed for MEDLINE]Related articlesFree article

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.

Hanefeld M, Brunetti P, Schernthaner GH, Matthews DR, Charbonnel BH; QUARTET Study Group.

Diabetes Care. 2004 Jan;27(1):141-7.PMID: 14693980 [PubMed - indexed for MEDLINE]Related articlesFree article

[New therapeutic approaches in diabetes]

Charbonnel B.

Ann Endocrinol (Paris). 2003 Oct;64(4):352-3. French. No abstract available. PMID: 14595253 [PubMed - indexed for MEDLINE]Related articles

Type 2 diabetes management: putting theory into practice--introduction.

Charbonnel B, Del Prato S.

Metabolism. 2003 Aug;52(8 Suppl 1):1-2. No abstract available. PMID: 12939731 [PubMed - indexed for MEDLINE]Related articles

Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.

Ouguerram K, Magot T, Zaïr Y, Marchini JS, Charbonnel B, Laouenan H, Krempf M.

J Pharmacol Exp Ther. 2003 Jul;306(1):332-7. Epub 2003 Apr 8.PMID: 12684543 [PubMed - indexed for MEDLINE]Related articlesFree article

[Present and future of insulin therapy in type 2 diabetic patients]

Charbonnel B, Sauvanet JP.

Diabetes Metab. 2001 Nov;27(5 Pt 3):S15-22. Review. French. PMID: 11910975 [PubMed - indexed for MEDLINE]Related articlesFree article

[Pheochromocytoma]

Arnault-Ouary G, Chatal JF, Charbonnel B.

Rev Prat. 1998 Apr 1;48(7):744-8. Review. French. PMID: 11767369 [PubMed - indexed for MEDLINE]Related articles

Which are the insulin treatment regimens used in France? The "Schema survey".

Charbonnel B, Balarac N, Cazeneuve B, Augendre-Ferrante B, Le Thaï F, Drouin P; Schema survey.

Diabetes Metab. 2001 Nov;27(5 Pt 1):591-7.PMID: 11694859 [PubMed - indexed for MEDLINE]Related articlesFree article

New advances in the management of insulin resistance in type 2 diabetes. Introduction.

Campbell IW, Charbonnel B.

Int J Clin Pract Suppl. 2001 Sep;(121):3. No abstract available. PMID: 11594242 [PubMed - indexed for MEDLINE]Related articles

Therapeutic perspectives for type 2 diabetes mellitus: molecular and clinical insights.

Mauvais-Jarvis F, Andreelli F, Hanaire-Broutin H, Charbonnel B, Girard J.

Diabetes Metab. 2001 Sep;27(4 Pt 1):415-23. Review.PMID: 11547215 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus.

Frénais R, Ouguerram K, Maugeais C, Mahot P, Charbonnel B, Magot T, Krempf M.

Atherosclerosis. 2001 Jul;157(1):131-5.PMID: 11427212 [PubMed - indexed for MEDLINE]Related articles

Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia.

Frénais R, Maugeais C, Ouguerram K, Zaïr Y, Bard JM, Charbonnel B, Magot T, Krempf M.

Metabolism. 2001 Jun;50(6):635-9.PMID: 11398137 [PubMed - indexed for MEDLINE]Related articles

In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.

Frénais R, Nazih H, Ouguerram K, Maugeais C, Zaïr Y, Bard JM, Charbonnel B, Magot T, Krempf M.

J Clin Endocrinol Metab. 2001 May;86(5):1962-7.PMID: 11344192 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.

Maugeais C, Ouguerram K, Frénais R, Maugère P, Charbonnel B, Magot T, Krempf M.

J Clin Endocrinol Metab. 2001 Apr;86(4):1679-86.PMID: 11297603 [PubMed - indexed for MEDLINE]Related articlesFree article